Loxo Oncology
Stamford, US · Founded 2013 · 2 known investors
Find your way into Loxo Oncology
Founders & leadership
Loxo Oncology was founded in 2013 by Joshua H. Bilenker.
JH
Joshua H. BilenkerFounder
Board
DG
JB
James BarrettBoard director
DB
David BonitaBoard director
SE

AN
Avi NaiderBoard director
KF
Keith FlahertyBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$23.9M disclosed across 1 round · 2014
▶$23.9MraisedMay 2014 · 7 investors · BiotechnologyRule 506(b)
▶$23.9MraisedMay 2014 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Avi NaiderDirector
- Dov GoldsteinDirector
- James BarrettDirector
- Keith FlahertyDirector
- David BonitaDirector
- Joshua H. BilenkerExecutive Officer, Director
- Steven ElmsDirector
- Offering amount
- $23.9M
- Amount sold
- $23.9M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Loxo Oncology?
- Loxo Oncology was founded by Joshua H. Bilenker in 2013.
- Who are Loxo Oncology's investors?
- Loxo Oncology's investors include Aisling Capital, New Enterprise Associates (NEA).
- How much funding has Loxo Oncology raised?
- Loxo Oncology has disclosed $23.9M raised across 1 round.
- Where is Loxo Oncology headquartered?
- Loxo Oncology is headquartered in Stamford, US.